1. Home
  2. ARTL vs SOPA Comparison

ARTL vs SOPA Comparison

Compare ARTL & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • SOPA
  • Stock Information
  • Founded
  • ARTL 2011
  • SOPA 2018
  • Country
  • ARTL United States
  • SOPA Singapore
  • Employees
  • ARTL N/A
  • SOPA N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • SOPA EDP Services
  • Sector
  • ARTL Health Care
  • SOPA Technology
  • Exchange
  • ARTL Nasdaq
  • SOPA Nasdaq
  • Market Cap
  • ARTL 6.7M
  • SOPA 7.3M
  • IPO Year
  • ARTL N/A
  • SOPA 2021
  • Fundamental
  • Price
  • ARTL $1.80
  • SOPA $1.89
  • Analyst Decision
  • ARTL Buy
  • SOPA Strong Buy
  • Analyst Count
  • ARTL 2
  • SOPA 1
  • Target Price
  • ARTL $30.00
  • SOPA $18.00
  • AVG Volume (30 Days)
  • ARTL 535.2K
  • SOPA 256.5K
  • Earning Date
  • ARTL 11-12-2025
  • SOPA 11-13-2025
  • Dividend Yield
  • ARTL N/A
  • SOPA N/A
  • EPS Growth
  • ARTL N/A
  • SOPA N/A
  • EPS
  • ARTL N/A
  • SOPA N/A
  • Revenue
  • ARTL N/A
  • SOPA $7,522,939.00
  • Revenue This Year
  • ARTL N/A
  • SOPA $26.32
  • Revenue Next Year
  • ARTL N/A
  • SOPA $13.64
  • P/E Ratio
  • ARTL N/A
  • SOPA N/A
  • Revenue Growth
  • ARTL N/A
  • SOPA 0.31
  • 52 Week Low
  • ARTL $1.66
  • SOPA $0.64
  • 52 Week High
  • ARTL $28.60
  • SOPA $6.75
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 23.01
  • SOPA 44.43
  • Support Level
  • ARTL $1.72
  • SOPA $1.75
  • Resistance Level
  • ARTL $2.24
  • SOPA $1.91
  • Average True Range (ATR)
  • ARTL 0.30
  • SOPA 0.23
  • MACD
  • ARTL -0.03
  • SOPA -0.13
  • Stochastic Oscillator
  • ARTL 4.10
  • SOPA 18.76

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

Share on Social Networks: